| abstract |
Compounds that are antagonists of the PGD 2 receptor are described herein. Other pharmaceutical compositions and medicaments comprising an antagonist of PGD 2 receptor as described herein, to treat respiratory, cardiovascular, and the disease or disorder other PGD 2 dependent or PGD 2 mediated Methods for using such PGD 2 receptor antagonists alone and in combination with other compounds are also described. [Selection figure] None |